Article Text
PDF
Statistics from Altmetric.com
In July 2002, I had the honour to be invited to give a 15 minute presentation on behalf of my country, Taiwan, on the topic of “Current system of national guidance on human subject protection in medical research” in a panel discussion of the Forum for Ethical Review Committees in Asia and the Western Pacific (Fercap), World Health Organization (WHO) international conference held in Chin-Mai, Thailand. In that conference, four delegates from Taiwan had a rare (because Taiwan is not a WHO member and is normally excluded from joining any WHO related activities) and therefore very precious opportunity to share Taiwan’s experience in establishing and promoting “human subject protection system” with delegates from 27 WHO member countries of the region. Through the vigorous exchanges of opinion in those four …
Read the full text or download the PDF:
Other content recommended for you
- Global rules for global health: why we need an independent, impartial WHO
- Are pharmaceutical patents protected by human rights?
- The WHO’s 75th anniversary: WHO at a pivotal moment in history
- The rationale of fever surveillance to identify patients with severe acute respiratory syndrome in Taiwan
- Severe acute respiratory syndrome (SARS): epidemiology and clinical features
- SARS: experience from the emergency department, Tan Tock Seng Hospital, Singapore
- Impact of an outbreak of severe acute respiratory syndrome on a hospital in Taiwan, ROC
- WHO membership: the plight of Taiwan
- Will international human rights subsume medical ethics? Intersections in the UNESCO Universal Bioethics Declaration
- Human rights and bioethics